Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors
- James L. Riley*,†,‡,
- Mao Mao§,
- Sumire Kobayashi§,
- Matt Biery§,
- Julja Burchard§,
- Guy Cavet§,
- Brian P. Gregson*,
- Carl H. June*, and
- Peter S. Linsley†,‡,§
- *Abramson Family Cancer Research Institute and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160; and §Rosetta Inpharmatics, Kirkland, WA 98034
-
Communicated by Gerald R. Crabtree, Stanford University School of Medicine, Stanford, CA (received for review February 15, 2002)
Abstract
Signals generated by T cell receptor (TCR) and CD28 engagement are required for optimal T cell activation, but how these signals integrate within the cell is still largely unknown. We have used near genome-scale expression profiling to monitor T cell signal transduction pathways triggered via TCR and/or costimulatory receptors. Ligation of CD28 alone induced a set of short-lived early response transcripts in both Jurkat T cells and primary CD4 T cells, thus providing evidence that CD28 engagement can affect gene regulation independently of TCR engagement. Simultaneous signaling through both the TCR and CD28 resulted in altered expression of several thousand genes following several distinct temporal patterns. Most of these gene regulations were induced by TCR signaling alone and were augmented to varying degrees by CD28 costimulation. CD28 and ICOS costimulation had nearly identical effects on gene regulation, but a few transcripts (e.g., IL2, IL9) were significantly more affected by CD28. Therefore, the distinctive functional outcomes of costimulation via CD28 and ICOS are accompanied by relatively few distinct differences in gene expression. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement selectively blocked augmentation of gene regulations by CD28-mediated costimulation, but did not ablate gene regulation induced by TCR triggering alone.
Footnotes
-
↵ † J.L.R. and P.S.L. contributed equally to this work
-
↵ ‡ To whom reprint requests may be addressed at: Abramson Family Cancer Research Institute, 508 BRB II/III, 421 Curie Boulevard, Philadelphia, PA 19104 (J.L.R.) or Rosetta Inpharmatics, 12040 115th Avenue Northeast, Kirkland, WA 98034 (P.S.L.). E-mail: rileyj{at}mail.med.upenn.edu or peter_linsley{at}merck.com.
- Abbreviations:
- CTLA-4,
- cytotoxic T lymphocyte antigen 4;
- TCR,
- T cell receptor
- Copyright © 2002, The National Academy of Sciences





